P
FBT icon

&Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

&Partners’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.7M Buy
78,413
+71,983
+1,119% +$14.9M 0.08% 241
2025
Q4 		$1.32M Sell
6,430
-178
-3% -$35.6K 0.01% 1075
2025
Q3 		$1.18M Sell
6,608
-159
-2% -$27.1K 0.01% 1006
2025
Q2 		$1.09M Buy
6,767
+3,930
+139% +$626K 0.01% 942
2025
Q1 		$468K Buy
2,837
+50
+2% +$8.68K 0.01% 1164
2024
Q4 		$468K Sell
2,787
-2,118
-43% -$362K 0.01% 1100
2024
Q3 		$843K Buy
+4,905
New +$812K 0.02% 634

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

&Partners's FBT Position: Q1 2026 in Review

&Partners increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1,119% in Q1 2026, buying an estimated $14.9M and bringing the position to 78,413 shares worth $15.7M. The position accounts for 0.08% of the portfolio, ranked #241.

&Partners first reported a position in FBT in Q3 2024 and has held it in 7 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • &Partners held 78,413 shares of First Trust NYSE Arca Biotechnology Index Fund worth $15.7M as of Q1 2026.
  • &Partners bought 71,983 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $14.9M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.08% of &Partners's portfolio in Q1 2026, its #241 holding.
  • &Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2024 and has held it in 7 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.